| Daclatasvir-like inhibitors of NS5A block early biogenesis of hepatitis C virus–induced membranous replication factories, independent of RNA replication C Berger, I Romero-Brey, D Radujkovic, R Terreux, M Zayas, D Paul, ... Gastroenterology 147 (5), 1094-1105. e25, 2014 | 172 | 2014 |
| Isoflavonoids in non-leguminous families: an update J Reynaud, D Guilet, R Terreux, M Lussignol, N Walchshofer Natural Product Reports 22 (4), 504-515, 2005 | 141 | 2005 |
| Delayed hypersensitivity to corticosteroids in a series of 315 patients: clinical data and patch test results M Baeck, JA Chemelle, R Terreux, J Drieghe, A Goossens Contact Dermatitis 61 (3), 163-175, 2009 | 103 | 2009 |
| Investigation of chalcones as selective inhibitors of the breast cancer resistance protein: critical role of methoxylation in both inhibition potency and cytotoxicity G Valdameri, C Gauthier, R Terreux, R Kachadourian, BJ Day, ... Journal of medicinal chemistry 55 (7), 3193-3200, 2012 | 102 | 2012 |
| Substituted chromones as highly potent nontoxic inhibitors, specific for the breast cancer resistance protein G Valdameri, E Genoux-Bastide, B Peres, C Gauthier, J Guitton, ... Journal of medicinal chemistry 55 (2), 966-970, 2012 | 96 | 2012 |
| Corticosteroid cross‐reactivity: clinical and molecular modelling tools M Baeck, JA Chemelle, A Goossens, JF Nicolas, R Terreux Allergy 66 (10), 1367-1374, 2011 | 96 | 2011 |
| Structure–activity relationship of natural and synthetic coumarins inhibiting the multidrug transporter P-glycoprotein I Raad, R Terreux, P Richomme, EL Matera, C Dumontet, J Raynaud, ... Bioorganic & medicinal chemistry 14 (20), 6979-6987, 2006 | 86 | 2006 |
| Identification of structural and molecular determinants of the tyrosine‐kinase Wzc and implications in capsular polysaccharide export E Bechet, J Gruszczyk, R Terreux, V Gueguen‐Chaignon, A Vigouroux, ... Molecular microbiology 77 (5), 1315-1325, 2010 | 79 | 2010 |
| Tyrosine dephosphorylation of the syndecan-1 PDZ binding domain regulates syntenin-1 recruitment B Sulka, H Lortat-Jacob, R Terreux, F Letourneur, P Rousselle Journal of Biological Chemistry 284 (16), 10659-10671, 2009 | 78 | 2009 |
| Interactions study between the copper II ion and constitutive elements of chitosan structure by DFT calculation R Terreux, M Domard, C Viton, A Domard Biomacromolecules 7 (1), 31-37, 2006 | 77 | 2006 |
| Flavonoids and tyrosine nitration: structure–activity relationship correlation with enthalpy of formation M Sadeghipour, R Terreux, J Phipps Toxicology in vitro 19 (2), 155-165, 2005 | 72 | 2005 |
| Synthesis and Antiviral Activity of Ethidium− Arginine Conjugates Directed Against the TAR RNA of HIV-1 V Peytou, R Condom, N Patino, R Guedj, AM Aubertin, N Gelus, C Bailly, ... Journal of medicinal chemistry 42 (20), 4042-4053, 1999 | 67 | 1999 |
| Localization of putative binding sites for cyclic guanosine monophosphate and the anti-cancer drug 5-fluoro-2′-deoxyuridine-5′-monophosphate on ABCC11 in silico models M Honorat, R Terreux, P Falson, A Di Pietro, C Dumontet, L Payen BMC Structural Biology 13, 1-12, 2013 | 66 | 2013 |
| Cyclic PNA hexamer-based compound: modelling, synthesis and inhibition of the HIV-1 RNA dimerization process C Schwergold, G Depecker, C Di Giorgio, N Patino, F Jossinet, ... Tetrahedron 58 (28), 5675-5687, 2002 | 62 | 2002 |
| Collateral sensitivity of resistant MRP1-overexpressing cells to flavonoids and derivatives through GSH efflux D Lorendeau, L Dury, E Genoux-Bastide, F Lecerf-Schmidt, ... Biochemical pharmacology 90 (3), 235-245, 2014 | 58 | 2014 |
| Surface charge modulation of rifampicin-loaded PLA nanoparticles to improve antibiotic delivery in Staphylococcus aureus biofilms D Da Costa, C Exbrayat-Héritier, B Rambaud, S Megy, R Terreux, ... Journal of nanobiotechnology 19, 1-17, 2021 | 57 | 2021 |
| Bacterial tyrosine-kinases: Structure–function analysis and therapeutic potential C Grangeasse, R Terreux, S Nessler Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics 1804 (3), 628-634, 2010 | 52 | 2010 |
| In silico, in vitro, and in vivo evaluation of new candidates for α-synuclein PET imaging M Verdurand, E Levigoureux, W Zeinyeh, L Berthier, M Mendjel-Herda, ... Molecular Pharmaceutics 15 (8), 3153-3166, 2018 | 49 | 2018 |
| Quinoxaline-substituted chalcones as new inhibitors of breast cancer resistance protein ABCG2: polyspecificity at B-ring position E Winter, GJ Gozzi, LD Chiaradia-Delatorre, N Daflon-Yunes, R Terreux, ... Drug Design, Development and Therapy, 609-619, 2014 | 45 | 2014 |
| Targeting the multidrug ABCG2 transporter with flavonoidic inhibitors: in vitro optimization and in vivo validation A Boumendjel, S Macalou, G Valdameri, A Pozza, C Gauthier, O Arnaud, ... Current medicinal chemistry 18 (22), 3387-3401, 2011 | 44 | 2011 |
